Thawed PBMC show low viability and weak responses. What would you check?

Why

Damage can happen at every step. Delay between blood draw and processing lowers yield and function. Freezing needs a controlled cooling rate and storage in the vapor phase of liquid nitrogen.

Warming events during transport or a freezer failure damage cells silently. The thaw itself matters. Ramachandran and colleagues found that adding ice-cold wash medium to thawed cells was a high-risk practice that lowered viability and ELISpot function.

Warming the vial to 37 C and adding warm medium did better. Cells could sit at 37 C in DMSO for up to 30 minutes without harm, which permits batch thawing. Viability read straight after thawing can mislead.

Kutscher and colleagues found that after an overnight rest, viability fell slightly because apoptosis-prone cells died, yet more antigen-specific T cells responded and responses became more polyfunctional. Clumping from DNA released by dead cells also lowers recovery.

How to work it through

1. Review the sample history: draw-to-freeze time, freezing medium, cooling method and storage temperature log.
2. Compare the failing vials with a control vial frozen and stored by a known good process.
3. Standardize the thaw with a 37 C water bath and warm wash medium added slowly.
4. Measure viability with a dye that separates dead from apoptotic cells, not only by trypan blue.
5. Include an overnight rest before stimulation and a positive control stimulus such as a viral peptide pool or a mitogen.

Where the answer stops holding

Some damage, such as slow processing at the clinical site, cannot be reversed in the lab. Resting changes the result itself, so rested and non-rested data should not be mixed in one study. Cell types differ in freezing tolerance.

Granulocytes and some myeloid cells survive poorly, so a PBMC sample does not represent every population equally.